Clinical trial
Optimizing the Effectiveness of Selective Serotonin Reuptake Inhibitors (SSRIs)…
NCT00093847 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00093847 |
|---|---|
| Title | Optimizing the Effectiveness of Selective Serotonin Reuptake Inhibitors (SSRIs) in Treatment-Resistant Depression |
| Official title | S-adenosyl Methionine (SAMe) Augmentation of Selective Serotonin Reuptake Inhibitors (SSRIs) for Treatment-Resistant Depression (TRD) |
| Lead sponsor | Massachusetts General Hospital, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Depression |
| Intervention type | Drug |
| Interventions | S-adenosyl methione (SAMe), Placebo |
| Enrollment | 73 |
| Start date | May 1, 2004 |
| Primary completion | Feb 1, 2009 |
| Completion | Feb 1, 2009 |
| First posted | Oct 8, 2004 |
| Last update posted | Oct 13, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: